Ejorango, Julieto M.
HRN: 231-23-59 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/21/2022
CIPROFLOXACIN 500MG (TAB)
04/21/2022
04/27/2022
PO
500
BID
COMPLICATED UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes